Surescripts: FTC must show predatory pricing, address Amex
The Federal Trade Commission must demonstrate that Surescripts implemented predatory pricing and caused anticompetitive harm to both sides of electronic prescription transactions, the health information company has said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10